IR-780联合阿霉素对肝癌干细胞样细胞的杀伤效应研究

廖星芸; 汪洋; 孙建国; 王昕; 史春梦

doi:10.16016/j.1000-5404.201611066

您当前的位置：

首页 >

文章列表页 >

IR-780联合阿霉素对肝癌干细胞样细胞的杀伤效应研究

基础医学 | 更新时间：2026-01-09

- IR-780联合阿霉素对肝癌干细胞样细胞的杀伤效应研究
- IR-780 enhances cytotoxicity of adriamycin against cancer stem-like cells from hepatocellular carcinoma cells
- 第三军医大学学报 2017年39卷第12期页码：1206-1212
- 作者机构：
  
  1.400038 重庆，第三军医大学军事预防医学院全军复合伤研究所，创伤、烧伤与复合伤国家重点实验室
  2.400037 重庆，第三军医大学新桥医院全军肿瘤研究所
- 作者简介：
  
  [史春梦, E-mail:shicm@sina.com Shi Chunmeng, E-mail: shicm@sina.com
- 基金信息：
  
  国家自然科学基金重点项目(81130026);重庆市研究生创新课题(2014年)
- DOI：10.16016/j.1000-5404.201611066
  中图分类号： R73-36;R735.7;R979.14
- 收稿：2016-11-08，
  
  修回：2017-02-10，
  
  纸质出版：2017-06-30
- 稿件说明：
移动端阅览
廖星芸, 汪洋, 孙建国, 等. IR-780联合阿霉素对肝癌干细胞样细胞的杀伤效应研究[J]. 第三军医大学学报, 2017,39(12):1206-1212.

Xingyun Liao, Yang Wang, Jianguo Sun, et al. IR-780 enhances cytotoxicity of adriamycin against cancer stem-like cells from hepatocellular carcinoma cells[J]. Journal of Third Military Medical University, 2017, 39(12): 1206-1212.
廖星芸, 汪洋, 孙建国, 等. IR-780联合阿霉素对肝癌干细胞样细胞的杀伤效应研究[J]. 第三军医大学学报, 2017,39(12):1206-1212. DOI： 10.16016/j.1000-5404.201611066.

Xingyun Liao, Yang Wang, Jianguo Sun, et al. IR-780 enhances cytotoxicity of adriamycin against cancer stem-like cells from hepatocellular carcinoma cells[J]. Journal of Third Military Medical University, 2017, 39(12): 1206-1212. DOI： 10.16016/j.1000-5404.201611066.

摘要

目的

探讨七甲川花菁类荧光小分子IR-780联合阿霉素对肝癌干细胞样细胞的杀伤作用。

方法

利用CCK-8试剂盒检测不同浓度IR-780(0、1.250、2.500、5.000、10.000、20.000 μmol/L)及IR-780联合阿霉素(0、0.025、0.050、0.100、0.200、0.400 μmol/L)对4种不同肝癌细胞(QGY-7703、SMMC-7721、Huh-7和HepG2) 的杀伤效应，并确定后续实验IR-780和阿霉素的浓度，采用细胞划痕实验检测IR-780联合阿霉素对肝癌细胞迁移能力的影响；采用无血清悬浮培养的方法从Huh-7细胞株中分离并鉴定出具有干细胞特性的肿瘤细胞，检测IR-780联合阿霉素对肝癌干细胞样细胞的杀伤作用及迁移能力的影响；在裸鼠皮下荷瘤模型中观察IR-780联合阿霉素对肝癌干细胞样细胞生长的抑制作用。

结果

低浓度的IR-780对肝癌细胞无明显杀伤作用；采用1.250 μmol/L的IR-780联合阿霉素可对多种肝癌细胞产生较强的杀伤作用，其中半数致死浓度LC

较单药阿霉素降低25%；采用无血清悬浮培养的方法培养出Huh-7细胞肿瘤球，比较其与贴壁细胞的克隆形成能力、致瘤能力和细胞周期分布，证明悬浮培养的肿瘤细胞具有肿瘤干细胞特性；IR-780联合阿霉素对肝癌干细胞样细胞具有较强的杀伤作用，单用阿霉素和IR-780联合阿霉素对肝癌干细胞样细胞的LC

差异有统计学意义[(0.30±0.02)

(0.22±0.04)μ

mol/L，

0.05

]

；IR-780联合阿霉素可明显抑制肝癌干细胞样细胞的迁移能力和裸鼠皮下肿瘤的生长。

结论

IR-780可增强阿霉素的抗肿瘤作用，提高对肝癌干细胞样细胞的杀伤效应。

Abstract

Objective

To determine the cytotoxic effects of adriamycin (ADM) in combination with heptamethine cyanine dye IR-780 iodide on cancer stem-like cells from hepatocellular carcinoma (HCC) cell line.

Methods

CCK-8 assay was used to detect the cell viability and LC

of ADM in the HCC cell lines QGY-7703

SMMC-7721

Huh-7 and HepG2 treated with IR-780 (0

1.250

2.500

5.000

10.000 or 20.000 μmol/L) alone or in combination with ADM (0

0.025

0.050

0.100

0.200 and 0.400 μmol/L). The effect of IR-780 combined with ADM on cell migration was assessed with scratch wound healing assay. Cancer stem-like cells were isolated from Huh-7 cells cultured in serum-free medium under non-adherent conditions and identified for their stemness. The effects of IR-780 combined with ADM on the cell viability

migration

and tumorigenicity of the cancer stem-like cells were evaluated both

in vitro

and inanude mouse model bearing the cell xenograft.

Results

Low-dose IR-780 (1.250 μmol/L) produced no significant cytotoxicity in the HCC cell lines. IR-780 at 1.250 μmol/L combined with ADM resulted inastrong cytotoxic effect in the cell lines withareduced LC

of ADM by 25% compared to that of ADM used alone. Comparison of the colony formation and tumorigenic abilities and cell cycle distribution between Huh-7 tumorspheres cultured in serum-free medium and the adherent cells demonstrated the stemness of the isolated cells. IR-780 combined with ADM showedastronger cytotoxic effect than ADM alone in the cancer stem-like cells withasignificantly reduced LC

of ADM (0.22±0.04

0.30±0.02 μmol/L

0.05). The combination of IR-780 and ADM

significantly inhibited the migration and tumorigenicity of the cancer stem-like cells both

in vitro

and in the tumor-bearing nude mouse model.

Conclusion

IR-780 can enhances the cytotoxic effect of ADM against cancer stem-like cells isolated from HCC cells.

关键词

Keywords

references

El-Serag H B. Hepatocellular carcinoma[J].N Engl J Med, 2011, 365(12): 1118-1127. DOI: 10.1056/NEJMra1001683.

Oikawa T. Cancer Stem cells and their cellular origins in primary liver and biliary tract cancers[J]. Hepatology, 2016, 64(2): 645-651. DOI: 10.1002/hep.28485.

Liu X D, Sun H, Liu G T. 5-Bromotetrandrine enhances the sensitivity of doxorubicin-induced apoptosis in intrinsic resistant human hepatic cancer Bel7402 cells[J]. Cancer Lett, 2010, 292(1): 24-31. DOI: 10.1016/j.canlet.2009.11.001.

Yang L, Liu X, Lu Z, et al . Ursolic acid induces doxorubicin-resistant HepG2 cell death via the release of apoptosis-inducing factor[J ] . Cancer Lett, 2010, 298(1): 128-138. DOI: 10.1016/j.canlet.2010.06.010..

Qian H, Yang Y, Wang X. Curcumin enhanced adriamycin-induced human liver-derived Hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagy[J]. Eur J Pharm Sci, 2011, 43(3): 125-131. DOI: 10.1016/j.ejps.2011.04.002.

Wang Y, Liu T, Zhang E, et al . Preferential accumulation of the near infrared heptamethine dye IR-780 in the mitochondria of drug-resistant lung cancer cells[J ] . Biomaterials, 2014, 35(13): 4116-4124. DOI: 10.1016/j.biomaterials.2014.01.061.

Huntly B J, Gilliland D G. Leukaemia stem cells and the evolution of cancer-stem-cell research[J]. Nat Rev Cancer, 2005, 5(4): 311-321. DOI: 10.1038/nrc1592.

Visvader J E, Lindeman G J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions[J]. Nat Rev Cancer, 2008, 8(10): 755-768. DOI: 10.1038/nrc2499.

Gao J, Li W, Guo Y, et al . Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells[J ] . Nanomedicine (Lond), 2016, 11(24): 3261-3282. DOI: 10.2217/nnm-2016-0261.

Eramo A, Lotti F, Sette G, et al . Identification and expansion of the tumorigenic lung cancer stem cell population[J ] . Cell Death Differ, 2008, 15(3): 504-514. DOI: 10.1038/sj.cdd.4402283.

McKenzie J L, Takenaka K, Gan O I, et al . Lowrhodamine123 retention identifies long-term human hematopoietic stem cell swithin the Lin-CD34 + CD38 - population[J ] . Blood, 2007, 109(2): 543-545. DOI:10.1182/blood-2006-06-030270..

Miranda-Lorenzo I, Dorado J, Lonardo E, et al . Intracellular autofluorescence:abiomarker for epithelial cancer stem cells[J ] . Nat Methods, 2014, 11(11): 1161-1169. DOI:10.1038/nmeth.3112.

Ponti D, Costa A, Zaffaroni N, et al . Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties[J ] . Cancer Res, 2005, 65(13): 5506-5511. DOI:10.1158/0008-5472.CAN-05-0626.

Fitzgerald T L, McCubrey J A. Pancreatic cancer stem cells: association with cell surface markers, prognosis, resistance, metastasis and treatment[J]. Adv Biol Regul, 2014, 56(3): 45-50. DOI: 10.1016/j.jbior.2014.05.001.

Shao J, Fan W, Ma B, et al . Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics[J ] . Mol Med Rep, 2016, 14(6): 4991-4998. DOI: 10.3892/mmr.2016.5899.

Magee J A, Piskounova E, Morrison S J. Cancer stem cells:impact, heterogeneity, and uncertainty[J]. Cancer Cell, 2012, 21(3): 283-296. DOI: 10.1016/j.ccr.2012.03.003.

Wang J, LiZ H, White J, et al . Lung cancer stem cells and implications for future therapeutics[J ] . Cell Biochem Biophys, 2014, 69(3): 389-398. DOI: 10.1007/s12013-014-9844-4.

赵笛, 郑青.悬浮培养在肿瘤干细胞研究中的应用及局限[J].肿瘤, 2012, 32(7): 559-563. DOI: 10.3781/j.issn.1000-7431.2012.07.015.

Zhao D, Zheng Q. The application and limitation of suspension culture in the study of neoplastic stem cells[J]. Tumor, 2012, 32(7): 559-563. DOI: 10.3781/j.issn.1000-7431.2012.07.015.

Zhang L, Jiao M, Li L, et al . Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties[J ] .JCancer Res Clin Oncol, 2012, 138(4): 675-686. DOI: 10.1007/s00432-011-1146-2.

Miranda-Lorenzo I, Dorado J, Lonardo E, et al . Intracellular autofluorescence:abiomarker for epithelial cancer stem cells[J ] . Nat Methods, 2014, 11(11): 1161-1169. DOI: 10.1038/nmeth.3112.

Zhang E, Luo S, Tan X, et al . Mechanistic study of IR-780 dye asapotential tumor targeting and drug delivery agent[J ] . Biomaterials, 2014, 35(2): 771-778. DOI: 10.1016/ j.biomaterials.2013.10.033.

Tan X, Luo S, Wang D, et al .A NIR heptamethine dye with intrinsic cancer targeting, imaging and photosensitizing properties[J ] . Biomaterials, 2012, 33(7): 2230-2239. DOI: 10.1016/j.biomaterials.2011.11.081.

Zhang C, Liu T, Su Y, et al .A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging[J ] . Biomaterials, 2010, 31(25): 6612-6617. DOI: 10.1016/j.biomaterials.2010.05.007..

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

PTPRZ 1单克隆抗体对胶质瘤干细胞自我更新和侵袭的抑制作用

抗菌肽ET12对革兰阳性菌的抗菌活性及机制研究

昼夜节律分子BMAL1通过调节免疫细胞毒性促进骨肉瘤的预后

司帕沙星对类风湿关节炎成纤维样滑膜细胞的声动力细胞毒性

铁离子通过ROS-乙酰化P53促进巨噬细胞M1型极化